medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2020, Number 03

<< Back Next >>

Ginecol Obstet Mex 2020; 88 (03)

Fasting plasmatic glucose changes during the menopausal transition

Inaraja V, Thuissard I, Andreu C, Jodar E

Language: Spanish
References: 17
Page: 146-153
PDF size: 210.61 Kb.


ABSTRACT

Objective: To evaluate the fasting plasmatic glucose changes during the menopausal transition.
Materials and Methods: This is a retrospective observational study of laboratory studies from women visited in hospital Quirón Salud de Madrid from 2007-2018 years. The inclusion criteria were one or more laboratory studies of fasting plasmatic glucose and lipid profile from women visited because of irregular menstruation, menopausal symptoms and/or amenorrhea. Laboratory studies values were classified as perimenopausal or posmenopausal based on their date of last menstruation. For quantitative variables, Student's T or Mann-Whitney U tests (depending on the normality distribution) were applied to analyze differences between perimenopausal and posmenopausal values. Chi-square or Fisher's exact test were used for qualitative variables. ANOVA test was performed to compare the glucose quartiles.
Results: 1949 laboratory reports of fasting glucose were included: 459 (23.6%) were perimenopausal and 1490 (76.4%) were posmenopausal, from 275 women with 7.3 laboratory report-women. Fasting plasmatic glucose was higher at the posmeno- hospitapausal samples (p ‹ 0.001). The evolution of the fasting plasmatic glucose showed a continuous increase that starts during perimenopause. There were no significant differences in the evolution trend between perimenopause and posmenopause. Age in the moment of the blood sample, gestational diabetes, family history of diabetes and triglycerides levels were independently associated with fasting plasmatic glucose (p ‹ 0.001 in all cases).
Conclusion: The differences in fasting blood glucose between periods of perimenopause and posmenopause are significant; however, data on age-adjusted blood glucose change and treatment suggest that menopausal status does not act independently on fasting blood glucose. Those that did influence were: age at the time of the measurements, gestational diabetes, family history of diabetes and triglyceride concentrations.


REFERENCES

  1. Barrett Connor EL, et al. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men?: The Rancho Bernardo Study. JAMA J Am Med Assoc 1991; 265 (5): 627-31. doi:10.1001/ jama.1991.03460050081025

  2. Barrett-Connor E WD. Sex differential in ischemic heart disease mortality in diabetics: a prospective populationbased study. Am J Epidemiol 1983; 118: 489-96. https:// doi.org/10.1093/oxfordjournals.aje.a113654

  3. Soriano JB, et al. The burden of disease in Spain: Results from the Global Burden of Disease 2016. Med Clin (Barc). 2018; 151 (5): 171-90. https://doi.org/10.1016/j.medcle. 2018.05.043

  4. Slopien R, et al. Menopause and diabetes: EMAS clinical guide. Maturitas. 2018; 117: 6-10. https://doi. org/10.1016/j.maturitas.2018.08.009

  5. Park HA, et al. Age, Menopause, and Cardiovascular Risk Factors. J Women´s Health. 2010; 19 (5): 869-76. https:// doi.org/10.1089/jwh.2009.1436

  6. Kim C, et al. Menopause and risk of diabetes in the Diabetes Prevention Program. Menopause. 2011; 18 (8): 857-68. 10.1097/gme.0b013e31820f62d0

  7. Jiang J, et al. Association Between Age at Natural Menopause and Risk of Type 2 Diabetes in Postmenopausal Obese and Non-Obese Females. J Clin Endocrinol Metab. 2019; 104: 3039-48. https://doi.org/10.1210/jc.2018-02310

  8. Guo C, et al. Association of age at menopause and type 2 diabetes: A systematic review and dose-response metaanalysis of cohort studies. Prim Care Diabetes. 2019; 13 (4): 301-9. https://doi.org/10.1016/j.pcd.2019.02.001

  9. Brand JS, et al. Age at menopause, reproductive life span, and type 2 diabetes risk: Results from the EPIC-InterAct study. Diabetes Care 2013; 36 (4): 1012-19. https://doi. org/10.2337/dc12-1020

  10. Wu SI, et al. The impact of years since menopause on the development of impaired glucose tolerance. J Clin Epidemiol. 2001; 54 (2): 117-20. https://doi.org/10.1016/ S0895-4356(00)00284-5

  11. Hu X, et al. Inverse association between physical activity and blood glucose is independent of sex, menopause status and first‐degree family history of diabetes. J Diabetes Investig 2019; 1-8. https://doi.org/10.1111/jdi.13062

  12. Gaspard UJ, et al. Postmenopausal changes of lipid and glucose metabolism: a review of their main aspects. Maturitas. 1995; 21 (3): 171-78. https://doi.org/10.1016/0378- 5122(95)00901-V

  13. Harlow SD, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10. Menopause. 2012; 19 (4): 387-95. https://doi.org/10.1210/jc.2011-3362

  14. Soriguer F, et al. Type 2 diabetes mellitus and other cardiovascular risk factors are no more common during menopause: Longitudinal study. Menopause. 2009; 16 (4): 817-21. doi: 10.1097/GME.0b013e31819d4113

  15. Otsuki M, et al. Menopause, but not age, is an independent risk factor for fasting plasma glucose levels in nondiabetic women. Menopause. 2007; 14 (3): 404-7. doi:10.1097/01. gme.0000247014.56254.12

  16. Matthews KA, et al. Are changes in cardiovascular disease risk factors in midlife women due to Chronological Aging or to the Menopausal transition? J Am Coll Cardiol. 2009; 54 (25): 2366-73. doi:10.1016/j.jacc.2009.10.009.Are

  17. Cuadros JL, et al. Body mass index and its correlation to metabolic and hormone parameters in posmenopausal Spanish women. Gynecol Endocrinol. 2011; 27 (9): 678-84. https://doi.org/10.3109/09513590.2010.521269




2020     |     www.medigraphic.com